Kory Wentworth
Finanzdirektor/CFO bei ENTRADA THERAPEUTICS, INC.
Vermögen: 275 211 $ am 31.05.2024
Profil
Kory James Wentworth's career history includes current and former positions as well as education.
Currently, he is the Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. Previously, he held the position of Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. from 2008 to 2017.
From 2017 to 2020, he worked as Treasurer & Vice President-Finance at bluebird bio, Inc. Prior to that, he was an Audit Manager at PricewaterhouseCoopers LLP from 2002 to 2008.
Mr. Wentworth obtained his undergraduate degree from Susquehanna University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ENTRADA THERAPEUTICS INC
0,05% | 16.04.2024 | 17 790 ( 0,05% ) | 275 211 $ | 31.05.2024 |
Aktive Positionen von Kory Wentworth
| Unternehmen | Position | Beginn |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.11.2020 |
Ehemalige bekannte Positionen von Kory Wentworth
| Unternehmen | Position | Ende |
|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 08.09.2020 |
| ALEXION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.12.2017 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | 01.12.2008 |
Ausbildung von Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
